Clinical Practice Guidelines - National Health and Medical Research ...

34. Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation
with radiofrequency. Cancer 2002; 94: 443–51.
35. Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency
ablation for hepatic malignancies. Surg Oncol Clin N Am 2003; 12: 243–55.
36. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of
focal liver tumors with percutaneous radio-frequency ablation: complications encountered in
a multicenter study. Radiology 2003; 226: 441–51.
37. Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and
radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003;
90: 1240–3.
38. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic
metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221:
159–66.
39. Ng KK, Lam CM, Poon RT, Ai V, Tso WK, Fan ST. Thermal ablative therapy for malignant
liver tumors: a critical appraisal. J Gastroenterol Hepatol 2003; 18: 616–29.
40. Erce C, Parks RW. Interstitial ablative techniques for hepatic tumours. Br J Surg 2003; 90:
272–89.
41. Garcea G, Lloyd TD, Aylott C, Maddern G, Berry DP. The emergent role of focal liver
ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer
2003; 39: 2150–64.
42. Goldberg SN. Comparison of techniques for image-guided ablation of focal liver tumors.
Radiology 2002; 223: 304–7.
43. Breedis C, Young C. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969–
85.
44. Vauthey JN, Marsh RW, Cendan JC, Chu NM, Copeland EM. Arterial therapy of hepatic
colorectal metastases. Br J Surg 1996; 83: 447–55.
45. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous
versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the
liver: the Northern California Oncology Group trial. J Clin Oncol 1989; 7: 1646–54.
46. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic
infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A
randomized trial. Ann Intern Med 1987; 107: 459–65.
47. Martin JK, Jr., O’Connell MJ, Wieand HS, et al. Intra-arterial floxuridine vs systemic
fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg
1990; 125: 1022–7.
48. Meta-analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of
nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996; 88: 252–8.
49. Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin
administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine
administered via hepatic arterial infusion in patients with nonresectable liver metastases from
colorectal carcinoma. J Clin Oncol 2000; 18: 243–54.
Management of liver and other distant metastases
239